Literature DB >> 10702785

HIV topic update: oro-genital transmission of HIV.

C Scully1, S Porter.   

Abstract

Several viruses, including the human immunodeficiency virus (HIV), can be found in blood and many body fluids including saliva, and are transmissible sexually across genital and particularly anal mucosae. A persisting concern has been the question of transmission of HIV by oral sexual practices. This review discusses the evidence for oro-genital transmission of HIV, detailing the presence and infectivity of HIV in genital fluids and saliva, the case reports and epidemiology of oro-genital HIV transmission, and the evidence from animal studies. Oral intercourse is not risk-free. The evidence suggests that the risk of HIV transmission from oro-genital sexual practices is substantially lower than that from penile-vaginal or penile-anal intercourse, that exposure to saliva presents a considerably lower risk than exposure to semen, and that oral trauma and ulcerative conditions might increase the risk of HIV transmission.

Entities:  

Mesh:

Year:  2000        PMID: 10702785     DOI: 10.1111/j.1601-0825.2000.tb00107.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  10 in total

1.  Personal and social influences regarding oral sex among African American female adolescents.

Authors:  Laura F Salazar; Sara Head; Richard A Crosby; Ralph J DiClemente; Jessica McDermott Sales; Gina M Wingood; Eve Rose
Journal:  J Womens Health (Larchmt)       Date:  2011-01-19       Impact factor: 2.681

2.  Oral and systemic health correlates of HIV-1 shedding in saliva.

Authors:  M Navazesh; R Mulligan; N Kono; S K S Kumar; M Nowicki; M Alves; W J Mack
Journal:  J Dent Res       Date:  2010-07-29       Impact factor: 6.116

3.  HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

4.  Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 5.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

6.  Impact of mucosal inflammation on oral simian immunodeficiency virus transmission.

Authors:  Luis D Giavedoni; Hui-Ling Chen; Vida L Hodara; Lianrui Chu; Laura M Parodi; Lisa M Smith; Valerie Sexton; David Cappelli; Donald L Sodora
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

7.  Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.

Authors:  Rossana Herrera; Michael Morris; Kristina Rosbe; Zhimin Feng; Aaron Weinberg; Sharof Tugizov
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

8.  Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia.

Authors:  Dalila Zachary; Lawrence Mwenge; Monde Muyoyeta; Kwame Shanaube; Albertus Schaap; Virginia Bond; Barry Kosloff; Petra de Haas; Helen Ayles
Journal:  BMC Infect Dis       Date:  2012-08-08       Impact factor: 3.090

Review 9.  Oral Health of Drug Abusers: A Review of Health Effects and Care.

Authors:  Hajar Shekarchizadeh; Mohammad R Khami; Simin Z Mohebbi; Hamed Ekhtiari; Jorma I Virtanen
Journal:  Iran J Public Health       Date:  2013-09       Impact factor: 1.429

Review 10.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.